Preserving the B-cell compartment favors operational tolerance in human renal transplantation

Molecular Medicine

Volumn 18, Issue 5, 2012, Pages 733-743

  Silva, Hernandez M ^a,b   Takenaka, Maisa C S ^a,b   Moraes Vieira, Pedro M M ^a,b   Monteiro, Sandra M ^a,b   Hernandez, Maristela O ^a,b   Chaara, Wahiba ^c,d,e   Six, Adrien ^c,d   Agena, Fabiana ^e   Sesterheim, Patrícia ^b,f   Barbé Tuana, Florencia Maria ^b,f   Saitovitch, David ^b,f   Lemos, Francine ^a   Kalil, Jorge ^a,b   Coelho, Verônica ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b National Institute of Science and Technology (INCT)   (Brazil)

^c SORBONNE UNIVERSITÉ   (France)

^d CNRS   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD40 ANTIGEN; STAT3 PROTEIN;

ADULT; ARTICLE; B CELL COMPARTMENT; B LYMPHOCYTE; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; MALE; MEMORY CELL; OPERATIONAL TOLERANCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; AGED; ANTIGENS, CD40; B-LYMPHOCYTES; B-LYMPHOCYTES, REGULATORY; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSPLANTATION TOLERANCE;

EID: 84861007222     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2011.00281     Document Type: Article

References (55)

1. Golshayan D, Pascual M. (2008) Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview. Drugs. 68:2113-30.
2. Hariharan S, et al. (2000) Improved graft survival after renal transplantation in the United States, 1988 to 1996. N. Engl. J. Med. 342:605-12.
3. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. (2002) Strategies to improve longterm outcomes after renal transplantation. N. Engl. J. Med. 346:580-90.
4. Fishman JA, Rubin RH. (1998) Infection in organtransplant recipients. N. Engl. J. Med. 338:1741-51.
5. Dantal J, et al. (1998) Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet. 351:623-8.
6. Hojo M, et al. (1999) Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature. 397:530-4.
7. Roberts CA, Stern DL, Radio SJ. (2002) Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclo-sporine A after liver transplant. Transplantation. 74:817-21.
8. Nankivell BJ, et al. (2004) Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation. 78:557-65.
9. Fuchimoto Y, et al. (2000) Mixed chimerism and tolerance without whole body irradiation in a large animal model. J. Clin. Invest. 105:1779-89.
10. Kawai T, et al. (2004) CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am. J. Transplant. 4:1391-8.
11. Wekerle T, et al. (2000) Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat. Med. 6:464-9.
12. Zoller KM, Cho SI, Cohen JJ, Harrington JT. (1980) Cessation of immunosuppressive therapy after successful transplantation: a national survey. Kidney Int. 18:110-4.
13. Louis S, et al. (2006) Contrasting CD25hiCD4+ T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation. 81:398-407.
14. Pons JA, et al. (2008) FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal. Transplantation. 86:1370-8.
15. Brouard S, et al. (2007) Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc. Natl. Acad. Sci. U. S. A. 104:15448-53.
16. Martinez-Llordella M, et al. (2008) Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J. Clin. Invest. 118:2845-57.
17. Braudeau C, et al. (2007) Variation in numbers of CD4(+)CD25(high)FOXP3(+) T cells with normal immuno-regulatory properties in long-term graft outcome. Transpl. Int. 20:845-55.
18. Moraes-Vieira PM, et al. (2010) Differential monocyte STAT6 activation and CD4(+)CD25(+)Foxp3(+) T cells in kidney operational tolerance transplanted individuals. Hum. Immunol. 71:442-50.
19. Pallier A, et al. (2010) Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int. 78:503-13.
20. Newell KA, et al. (2010) Identification of a B cell signature associated with renal transplant tolerance in humans. J. Clin. Invest. 120:1836-47.
21. Swain SL, Dutton RW. (1987) Consequences of the direct interaction of helper T cells with B cells presenting antigen. Immunol. Rev. 99:263-80.
22. Pierce SK, et al. (1988) Antigen-presenting function of B lymphocytes. Immunol. Rev. 106:149-80.
23. Mizoguchi A, Bhan AK. (2006) A case for regulatory B cells. J. Immunol. 176:705-10.
24. Harris DP, et al. (2000) Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1:475-82.
25. Harris DP, Goodrich S, Gerth AJ, Peng SL, Lund FE. (2005) Regulation of IFN-gamma production by B effector 1 cells: essential roles for T-bet and the IFN-gamma receptor. J. Immunol. 174:6781-90.
26. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. (2002) B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3:944-50.
27. Mauri C, Gray D, Mushtaq N, Londei M. (2003) Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197:489-501.
28. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. (2002) Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity. 16:219-30.
29. Yanaba K, et al. (2008) A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 28:639-50.
30. Blair PA, et al. (2009) Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J. Immunol. 182:3492-502.
31. Iwata Y, et al. (2010) Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 117:530-41.
32. Blair PA, et al. (2010) CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 32:129-40.
33. Shevach EM. (2006) From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity. 25:195-201.
34. Racusen LC, Halloran PF, Solez K. (2004) Banff 2003 meeting report: new diagnostic insights and standards. Am. J. Transplant. 4:1562-6.
35. Solez K, et al. (2007) Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am. J. Transplant. 7:518-26.
36. Cockcroft DW, Gault MH. (1976) Prediction of creatinine clearance from serum creatinine. Nephron. 16:31-41.
37. Carsetti R, Rosado MM, Wardmann H. (2004) Peripheral development of B cells in mouse and man. Immunol. Rev. 197:179-91.
38. Sims GP, et al. (2005) Identification and characterization of circulating human transitional B cells. Blood. 105:4390-8.
39. Lim A, et al. (2008) Many human peripheral VH5-expressing IgM+ B cells display a unique heavy-chain rearrangement. Int. Immunol. 20:105-16.
40. van Dongen JJ, et al. (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lympho-proliferations: report of the BIOMED-2 Con-certed Action BMH4-CT98-3936. Leukemia. 17:2257-317.
41. Collette A, Cazenave PA, Pied S, Six A. (2003) New methods and software tools for high throughput CDR3 spectratyping: application to T lymphocyte repertoire modifications during experimental malaria. J. Immunol. Methods. 278:105-16.
42. Collette A, Six A. (2002) ISEApeaks: an Excel platform for GeneScan and Immunoscope data retrieval, management and analysis. Bioinformatics. 18:329-30.
43. Cochet M, et al. (1992) Molecular detection and in vivo analysis of the specific T cell response to a protein antigen. Eur. J. Immunol. 22:2639-47.
44. Hori S, Collette A, Demengeot J, Stewart J. (2002) A new statistical method for quantitative analyses: application to the precise quantification of T cell receptor repertoires. J. Immunol. Methods. 268:159-70.
45. Pannetier C, et al. (1993) The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. U. S. A. 90:4319-23.
46. Wu CJ, et al. (2000) Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. Blood. 95:352-9.
47. Wehner JR, et al. (2010) B cells and plasma cells in coronaries of chronically rejected cardiac transplants. Transplantation. 89:1141-8.
48. Steinmetz OM, Stahl RA, Panzer U. (2009) Chemokines and B cells in renal inflammation and allograft rejection. Front. Biosci. (Schol. Ed.) 1:13-22.
49. Steinmetz OM, et al. (2005) BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection. Kidney Int. 67:1616-21.
50. Cornell LD, Smith RN, Colvin RB. (2008) Kidney transplantation: mechanisms of rejection and acceptance. Annu. Rev. Pathol. 3:189-220.
51. Mizoguchi A, Mizoguchi E, Smith RN, Preffer FI, Bhan AK. (1997) Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J. Exp. Med. 186:1749-56.
52. Iwata Y, et al. (2011) Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 117:530-41.
53. Vieira PM, et al. (2010) Differential monocyte STAT6 activation and CD4+CD25+Foxp3+ T cell in kidney operational tolerance transplanted individuals. Hum Immunol. 71:442-50.
54. Braudeau C, et al. (2007) Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome. Transpl. Int. 20:845-55.
55. Braudeau C, et al. (2008) Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients. Transplantation. 86:130-6.